In women with polycystic ovary syndrome, metformin administration, not laparoscopic ovarian drilling, reduces plasminogen activator inhibitor 1 (PAI-1) activity. The lack of a decrease in PAI-1 activity is related to a high risk for miscarriage.
Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome / Palomba, S; Orio, F Jr; Falbo, A; Russo, T; Tolino, A; Zullo, F.. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - 84:3(2005), pp. 761-765. [10.1016/j.fertnstert.2005.04.021]
Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome
Palomba S
;
2005
Abstract
In women with polycystic ovary syndrome, metformin administration, not laparoscopic ovarian drilling, reduces plasminogen activator inhibitor 1 (PAI-1) activity. The lack of a decrease in PAI-1 activity is related to a high risk for miscarriage.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Palomba_Plasminogen-activator-inhibitor_2005.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
99.82 kB
Formato
Adobe PDF
|
99.82 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
